Open AccessEffect of vildagliptin as add-on therapy to a low-dose metformin
Author(s) -
Claudia Filozof,
Sherwyn Schwartz,
James E. Foley
Publication year - 2010
Publication title -
world journal of diabetes
Language(s) - English
Resource type - Journals
ISSN - 1948-9358
DOI - 10.4239/wjd.v1.i1.19
Subject(s) - vildagliptin , metformin , medicine , clinical endpoint , diabetes mellitus , type 2 diabetes , adverse effect , confidence interval , dipeptidyl peptidase 4 inhibitor , type 2 diabetes mellitus , gastroenterology , pharmacology , endocrinology , randomized controlled trial
To evaluate the efficacy and safety of the addition of vildagliptin to low-dose metformin and compare it to an uptitration of metformin in type 2 diabetes mellitus (T2DM) patients who have inadequate control with metformin monotherapy.